Literature DB >> 22349300

Villin expression is frequently lost in poorly differentiated colon cancer.

Diego Arango1, Sheren Al-Obaidi, David S Williams, Higinio Dopeso, Rocco Mazzolini, Georgia Corner, Do-Sun Byun, Azadeh A Carr, Carmel Murone, Lars Tögel, Nikolajs Zeps, Lauri A Aaltonen, Barry Iacopetta, John M Mariadason.   

Abstract

Colorectal cancers (CRCs) are classified as having microsatellite instability (MSI) or chromosomal instability (CIN); herein termed microsatellite stable (MSS). MSI colon cancers frequently display a poorly differentiated histology for which the molecular basis is not well understood. Gene expression and immunohistochemical profiling of MSS and MSI CRC cell lines and tumors revealed significant down-regulation of the intestinal-specific cytoskeletal protein villin in MSI colon cancer, with complete absence in 62% and 17% of MSI cell lines and tumors, respectively. Investigation of 577 CRCs linked loss of villin expression to poorly differentiated histology in MSI and MSS tumors. Furthermore, mislocalization of villin from the membrane was prognostic for poorer outcome in MSS patients. Loss of villin expression was not due to coding sequence mutations, epigenetic inactivation, or promoter mutation. Conversely, in transient transfection assays villin promoter activity reflected endogenous villin expression, suggesting transcriptional control. A screen of gut-specific transcription factors revealed a significant correlation between expression of villin and the homeobox transcription factor Cdx-1. Cdx-1 overexpression induced villin promoter activity, Cdx-1 knockdown down-regulated endogenous villin expression, and deletion of a key Cdx-binding site within the villin promoter attenuated promoter activity. Loss of Cdx-1 expression in CRC lines was associated with Cdx-1 promoter methylation. These findings demonstrate that loss of villin expression due to Cdx-1 loss is a feature of poorly differentiated CRCs.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349300      PMCID: PMC5426554          DOI: 10.1016/j.ajpath.2012.01.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Transcriptional networks and signaling pathways that govern vertebrate intestinal development.

Authors:  Joan K Heath
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

2.  Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2.

Authors:  Michael P Verzi; Hyunjin Shin; H Hansen He; Rita Sulahian; Clifford A Meyer; Robert K Montgomery; James C Fleet; Myles Brown; X Shirley Liu; Ramesh A Shivdasani
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

3.  Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Authors:  Namsoo Suh; Ximing J Yang; Maria S Tretiakova; Peter A Humphrey; Hanlin L Wang
Journal:  Mod Pathol       Date:  2005-09       Impact factor: 7.842

4.  Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue.

Authors:  C E Bacchi; A M Gown
Journal:  Lab Invest       Date:  1991-03       Impact factor: 5.662

5.  The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

Authors:  Ajay Goel; Takeshi Nagasaka; Christian N Arnold; Toru Inoue; Cody Hamilton; Donna Niedzwiecki; Carolyn Compton; Robert J Mayer; Richard Goldberg; Monica M Bertagnolli; C Richard Boland
Journal:  Gastroenterology       Date:  2006-09-20       Impact factor: 22.682

6.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

Authors:  Monica M Bertagnolli; Donna Niedzwiecki; Carolyn C Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

8.  GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.

Authors:  Yoshimitsu Akiyama; Neil Watkins; Hiromu Suzuki; Kam-Wing Jair; Manon van Engeland; Manel Esteller; Hidekazu Sakai; Chun-Yan Ren; Yasuhito Yuasa; James G Herman; Stephen B Baylin
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.

Authors:  R Soong; N Shah; M Salto-Tellez; B C Tai; R A Soo; H C Han; S S Ng; W L Tan; N Zeps; D Joseph; R B Diasio; B Iacopetta
Journal:  Ann Oncol       Date:  2008-02-01       Impact factor: 32.976

10.  Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

Authors:  M Kruhøffer; J L Jensen; P Laiho; L Dyrskjøt; R Salovaara; D Arango; K Birkenkamp-Demtroder; F B Sørensen; L L Christensen; L Buhl; J-P Mecklin; H Järvinen; T Thykjaer; F P Wikman; F Bech-Knudsen; M Juhola; N N Nupponen; S Laurberg; C L Andersen; L A Aaltonen; T F Ørntoft
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

View more
  14 in total

1.  Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.

Authors:  Janneke F Linnekamp; Sander R van Hooff; Pramudita R Prasetyanti; Raju Kandimalla; Joyce Y Buikhuisen; Evelyn Fessler; Prashanthi Ramesh; Kelly A S T Lee; Grehor G W Bochove; Johan H de Jong; Kate Cameron; Ronald van Leersum; Hans M Rodermond; Marek Franitza; Peter Nürnberg; Laura R Mangiapane; Xin Wang; Hans Clevers; Louis Vermeulen; Giorgio Stassi; Jan Paul Medema
Journal:  Cell Death Differ       Date:  2018-01-05       Impact factor: 15.828

2.  T-oligo as an anticancer agent in colorectal cancer.

Authors:  Luke Wojdyla; Neelu Puri; Amanda L Stone; Nan Sethakorn; Srijayaprakash B Uppada; Joseph T Devito; Marc Bissonnette
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

3.  The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.

Authors:  Matthew F Jones; Toshifumi Hara; Princy Francis; Xiao Ling Li; Sven Bilke; Yuelin Zhu; Marbin Pineda; Murugan Subramanian; Walter F Bodmer; Ashish Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Authors:  Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey
Journal:  Carcinogenesis       Date:  2015-04-27       Impact factor: 4.944

5.  Both the anti- and pro-apoptotic functions of villin regulate cell turnover and intestinal homeostasis.

Authors:  Yaohong Wang; Sudeep P George; Swati Roy; Eric Pham; Amin Esmaeilniakooshkghazi; Seema Khurana
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

6.  Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity.

Authors:  Jenny Paredes; Ping Ji; Joseph F Lacomb; Kenneth R Shroyer; Laura A Martello; Jennie L Williams
Journal:  Int J Oncol       Date:  2018-07-31       Impact factor: 5.650

7.  Loss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survival.

Authors:  Jaudah Al-Maghrabi; Wafaey Gomaa; Abdelbaset Buhmeida; Mohmmad Al-Qahtani; Mahmoud Al-Ahwal
Journal:  ISRN Gastroenterol       Date:  2013-09-05

8.  Evidence for the importance of personalized molecular profiling in pancreatic cancer.

Authors:  Loukia N Lili; Lilya V Matyunina; L DeEtte Walker; George W Daneker; John F McDonald
Journal:  Pancreas       Date:  2014-03       Impact factor: 3.327

9.  N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.

Authors:  Stephanie Holst; Anna J M Deuss; Gabi W van Pelt; Sandra J van Vliet; Juan J Garcia-Vallejo; Carolien A M Koeleman; André M Deelder; Wilma E Mesker; Rob A Tollenaar; Yoann Rombouts; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2015-11-04       Impact factor: 5.911

10.  By moonlighting in the nucleus, villin regulates epithelial plasticity.

Authors:  Srinivas Patnaik; Sudeep P George; Eric Pham; Swati Roy; Kanchan Singh; John M Mariadason; Seema Khurana
Journal:  Mol Biol Cell       Date:  2015-12-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.